CHEMOTHERAPY FOR RECURRENT AND METASTATIC CERVICAL-CANCER WITH STANDARD-DOSE METHOTREXATE-LEUCOVORIN, BLEOMYCIN AND CISPLATINUM

被引：0
作者：
VOGL, SE
SELTZER, V
CAMACHO, F
DAVIS, TE
机构：
[1] WISCONSIN CLIN CANC CTR,MADISON,WI
[2] YESHIVA UNIV ALBERT EINSTEIN COLL MED,BRONX,NY 10461
[3] SUNY STONY BROOK,STONY BROOK,NY 11794
来源：
JOURNAL OF REPRODUCTIVE MEDICINE | 1986年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：327 / 329
页数：3
相关论文
共 50 条
[21]   CONCURRENT WEEKLY CISPLATINUM AND RADIOTHERAPY IN ADVANCED CERVICAL-CANCER - A PRELIMINARY DOSE ESCALATING TOXICITY STUDY [J].
TWIGGS, LB ;
POTISH, RA ;
MCINTYRE, S ;
ADCOCK, LL ;
SAVAGE, JE ;
PREM, KA .
GYNECOLOGIC ONCOLOGY, 1986, 24 (02) :143-148
[22]   EFFICACY OF ADJUVANT CHEMOTHERAPY IN METASTATIC CERVICAL-CANCER - A PILOT-STUDY [J].
KEMNITZ, T ;
KRAFFT, W ;
GLASER, F ;
SCHIRMER, A .
JOURNAL OF CHEMOTHERAPY, 1993, 5 :688-689
[23]   Chemotherapy in the treatment of metastatic, persistent, and recurrent cervical cancer [J].
Eskander, Ramez N. ;
Tewari, Krishnansu S. .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (04) :314-321
[24]   Prognostic value of Her2 overexpression in patients with metastatic breast cancer treated with standard-dose chemotherapy or high-dose consolidation chemotherapy [J].
Bengala, C ;
Guarneri, V ;
Salvadori, B ;
Landucci, E ;
Donati, S ;
Orlandini, C ;
Campani, D ;
Collecchi, P ;
Bevilacqua, G ;
Conte, PF .
BONE MARROW TRANSPLANTATION, 2003, 31 :S36-S36
[25]   HIGH-DOSE METHOTREXATE WITH LEUCOVORIN RESCUE, VINBLASTINE, AND BLEOMYCIN WITH OR WITHOUT TAMOXIFEN IN METASTATIC RENAL-CELL CARCINOMA [J].
BELL, DR ;
ARONEY, RS ;
FISHER, RJ ;
LEVI, JA .
CANCER TREATMENT REPORTS, 1984, 68 (04) :587-590
[26]   RESPONSE RATE AND CELL-CYCLE CHANGES DUE TO INTRAARTERIAL INFUSION CHEMOTHERAPY WITH CISPLATIN AND BLEOMYCIN FOR LOCALLY RECURRENT UTERINE CERVICAL-CANCER [J].
KIGAWA, J ;
KANAMORI, Y ;
ISHIHARA, H ;
MINAGAWA, Y ;
IWAMOTO, K ;
TERAKAWA, N .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (06) :474-479
[27]   A PHASE-II TRIAL OF IFOSFAMIDE, 5-FLUOROURACIL, AND LEUCOVORIN IN RECURRENT UTERINE CERVICAL-CANCER [J].
STORNES, I ;
MEJLHOLM, I ;
JAKOBSEN, A .
GYNECOLOGIC ONCOLOGY, 1994, 55 (01) :123-125
[28]   Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review [J].
Hirte, H. W. ;
Strychowskyz, J. E. ;
Oliverz, T. ;
Fung-Kee-Fung, M. ;
Elit, L. ;
Oza, A. M. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (06) :1194-1204
[29]   The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer [J].
Tambaro, R ;
Scambia, G ;
Di Maio, M ;
Pisano, C ;
Barletta, E ;
Iaffaioli, VR ;
Pignata, S .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) :33-44
[30]   Chemotherapy in recurrent and metastatic cervical cancer: single agent versus combination chemotherapy [J].
Kumar, L ;
Pokharel, YH ;
Kumar, S ;
Singh, R ;
Rath, GK ;
Kochupillai, V .
17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, :1225-1228
12345